InvestorsHub Logo
Followers 27
Posts 1014
Boards Moderated 0
Alias Born 08/19/2016

Re: A deleted message

Wednesday, 12/14/2016 11:11:10 AM

Wednesday, December 14, 2016 11:11:10 AM

Post# of 403599
Hound the headlines from the PR....You tell me what it says..

"Cellceutix Phase 2 Trial Dose Escalates in 2nd Cohort for Brilacidin as a Novel Anti-Inflammatory Drug Candidate for Ulcerative Colitis
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News